en
Scientific article
English

Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis

Published inRheumatology, vol. 55, no. 2, p. 230-236
Publication date2016
Abstract

To compare the effectiveness of biologics after rituximab (RTX) treatment in RA.

Keywords
  • Antirheumatic Agents/therapeutic use
  • Arthritis, Rheumatoid/drug therapy
  • Disease Progression
  • Europe
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Registries
  • Rituximab/therapeutic use
  • Time Factors
  • Treatment Outcome
Citation (ISO format)
WALKER, Ulrich A et al. Rituximab done: what’s next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis. In: Rheumatology, 2016, vol. 55, n° 2, p. 230–236. doi: 10.1093/rheumatology/kev297
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1462-0324
466views
0downloads

Technical informations

Creation08/31/2016 4:51:00 PM
First validation08/31/2016 4:51:00 PM
Update time03/15/2023 12:41:55 AM
Status update03/15/2023 12:41:54 AM
Last indexation01/16/2024 9:40:36 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack